DHR vs XGN · P/E 39, rev $6.26B vs rev $37.2M
Danaher Corporation (DHR) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. XGN currently screens at market cap $154.1M.
Not investment advice. Open the DHR and XGN stock pages for the full models.
Not investment advice.